Entity Common Stock, Shares Outstanding of ROCKET PHARMACEUTICALS, INC. from 13 May 2015 to 20 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ROCKET PHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 13 May 2015 to 20 Feb 2026.
  • ROCKET PHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 20 Feb 2026 was 108,569,143, a 0.77% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ROCKET PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 108,569,143 +831,224 +0.77% 20 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 108,222,228 +17,065,143 +19% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 107,903,871 +16,928,012 +19% 01 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 107,737,919 +16,955,708 +19% 02 May 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 91,157,085 +998,190 +1.1% 05 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 90,975,859 +10,450,328 +13% 02 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 90,782,211 +10,320,876 +13% 01 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 90,158,895 +14,474,472 +19% 03 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 80,525,531 +14,482,159 +22% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 80,461,335 +14,623,441 +22% 01 May 2023 10-Q 05 May 2023 2023 Q1
Q3 2022 75,684,423 +11,241,822 +17% 01 Nov 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 66,043,372 +2,427,687 +3.8% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 65,837,894 +2,440,940 +3.8% 02 May 2022 10-Q 06 May 2022 2022 Q1
Q3 2021 64,442,601 +9,208,803 +17% 04 Nov 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 63,615,685 +8,428,086 +15% 02 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 63,396,954 +8,325,760 +15% 03 May 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 55,233,798 +4,857,768 +9.6% 02 Nov 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 55,187,599 +4,839,164 +9.6% 03 Aug 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 55,071,194 +9,956,757 +22% 02 Mar 2020 10-K 06 Mar 2020 2019 FY
Q3 2019 50,376,030 +10,540,530 +26% 04 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 50,348,435 +10,687,541 +27% 05 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 45,114,437 +5,712,414 +14% 01 Mar 2019 10-K 08 Mar 2019 2018 FY
Q3 2018 39,835,500 +12,612,755 +46% 08 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 39,660,894 +12,650,692 +47% 13 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 39,402,023 +12,415,705 +46% 01 Mar 2018 10-K 07 Mar 2018 2017 FY
Q3 2017 27,222,745 +292,015 +1.1% 03 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 27,010,202 +79,472 +0.3% 03 Aug 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 26,986,318 +562,924 +2.1% 15 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 26,930,730 +520,479 +2% 08 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 26,930,730 +6,733,014 +33% 09 Aug 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 26,423,394 +10,096,391 +62% 22 Mar 2016 10-K 23 Mar 2016 2015 FY
Q3 2015 26,410,251 11 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 20,197,716 06 Aug 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 16,327,003 13 May 2015 10-Q 14 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.